Large-scale testing (Phase 3)Study completedNCT00753454
What this trial is testing
Open Label Extension for Patients Coming From the Dosing Flexibility Study in Patients With Rheumatoid Arthritis (RA)
Who this might be right for
Rheumatoid Arthritis
UCB Pharma 168